Safety operating costs effect

Deactivation and D D actions can range from stabilization of multiple hazards at a single site or facilities containing chemical or radioactive contamination, or both, to routine asbestos and lead abatement in a nonindustrial structure. Strategies include programs that meet compliance objectives, protect workers, and make certain that productivity and cost-effectiveness are maintained. The content and extent of health and safety-related programs should be proportionate to the types and degrees of hazards and risks associated with specific operations. 

The Severe Accident Policy Statement formulates systematic safety examinations for detection of accident vulnerabilities and implementation of cost-effective changes. The NRC issued Generic Letter 88-20 to implement this plan through IPEs. While the primary goal was the identification of plant vulnerabilities, no definition of vulnerability was provided. Only 4 operators of BWRs identified vulnerabilities and only 16 operators of PWRs did so. Over 500 plant improvements were identified, but few vulnerabilities were. 

It is emphasized that the above checklist is not exhaustive. Any reductions in the standards identified above will lead to difficulty of operation, tire scmb, potential damage to vehicles and buildings, and general inefficiency. Cost effectiveness could also be hindered due to loss of time caused by blocked-in vehicles. Safety is also a highly important factor, which should be prominent in any decision-making. 

Significant opportunities exist for industry to reduce or prevent pollution through cost-effective changes in production, operation, and raw materials use. In addition, such changes may offer industry substantial savings in reduced raw materials, pollution control, and liability costs, as well as protect the environment and reduce health and safety risks to workers. Where pollution prevention practices can be both environmentally beneficial and economically feasible, one would consider their implementation to be prudent. 

An inherently safe plant1112 relies on chemistry and physics to prevent accidents rather than on control systems, interlocks, redundancy, and special operating procedures to prevent accidents. Inherently safer plants are tolerant of errors and are often the most cost effective. A process that does not require complex safety interlocks and elaborate procedures is simpler, easier to operate, and more reliable. Smaller equipment, operated at less severe temperatures and pressures, has lower capital and operating costs. 

To conclude, it is clearly evident that none of the mass deacidification processes just discussed meet the "ideal" criteria set forth in Table I. Without consideration of cost effectiveness and safety of operation, the Library of Congress DEZ process seems to be the winner. However, as a mass deacidification process the Koppers "Book Keeping" process may have more potential due to its straightforward and danger-free operation. 

Controls. Process consistency is a function of equipment and process repeatability. Design and manufacturing quality is also very important. All systems should be supplied with a control strategy that allows automatic cycling. Automatic operation improves consistency, safety and reliability, and reduces the labor content, assuring efficient and cost effective operation. 

However, subjective and objective analyses of these devices are required to make sure both scientific, regulatory and consumer needs are met. The devices in development are costlier and more complicated when compared with conventional transdermal patch therapies. As such they may contain electrical and mechanical components which could increase the potential safety risks to patients because of poor operator technique or device malfunction. In addition, effects of the device on the skin must be reversible, since any permanent damage to the SC will result in the loss of its barrier properties and hence its function as a protective organ. Regulatory bodies will also require data to substantiate the safety of the device on the skin for either short- or long-term use. Thus, for any of these novel drug delivery technologies to succeed and compete with those already on the market, their safety, efficacy, portability, user-friendliness, cost-effectiveness and potential market have to be addressed. 

The value of R is often dictated by the design of the grouting operation. The preceding equation can thus be used as a coarse check on whether the parameters Q and H fall within cost-effectiveness and safety. For a cylindrical injection source of length L and diameter D, r may be taken as l/2x/LD. Also on a coarse level, the indication is that grout acceptance will vary directly with the pressure, and inversely with the viscosity. 

---